Your browser doesn't support javascript.
Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005].
Lee, R J; Wysocki, O; Bhogal, T; Shotton, R; Tivey, A; Angelakas, A; Aung, T; Banfill, K; Baxter, M; Boyce, H; Brearton, G; Copson, E; Dickens, E; Eastlake, L; Gomes, F; Hague, C; Harrison, M; Horsley, L; Huddar, P; Hudson, Z; Khan, S; Khan, U T; Maynard, A; McKenzie, H; Palmer, D; Robinson, T; Rowe, M; Thomas, A; Tweedy, J; Sheehan, R; Stockdale, A; Weaver, J; Williams, S; Wilson, C; Zhou, C; Dive, C; Cooksley, T; Palmieri, C; Freitas, A; Armstrong, A C.
  • Lee RJ; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. Electronic address: Rebecca.lee-3@manchester.ac.uk.
  • Wysocki O; The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
  • Bhogal T; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
  • Shotton R; The Christie NHS Foundation Trust, Manchester, UK.
  • Tivey A; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
  • Angelakas A; University Hospitals of Morecambe Bay, Kendal, UK.
  • Aung T; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Banfill K; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
  • Baxter M; University of Dundee, Dundee, UK.
  • Boyce H; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Brearton G; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Copson E; Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Dickens E; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
  • Eastlake L; University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Gomes F; The Christie NHS Foundation Trust, Manchester, UK.
  • Hague C; The Christie NHS Foundation Trust, Manchester, UK.
  • Harrison M; Ninewells Hospital, Dundee, UK.
  • Horsley L; The Christie NHS Foundation Trust, Manchester, UK.
  • Huddar P; Lancashire Teaching Hospitals NHS Trust, Preston, UK.
  • Hudson Z; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Khan S; Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Khan UT; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
  • Maynard A; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • McKenzie H; Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Palmer D; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
  • Robinson T; Bristol Haematology and Oncology Centre, Bristol, UK; Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK.
  • Rowe M; National Institute for Biological Standards and Control, Potters Bar, UK.
  • Thomas A; Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Tweedy J; Institute of Infection and Global Health, University of Liverpool and Tropical and Infectious Diseases Unit, Royal Liverpool Hospital, Liverpool, UK.
  • Sheehan R; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Stockdale A; Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
  • Weaver J; The Christie NHS Foundation Trust, Manchester, UK.
  • Williams S; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Wilson C; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Zhou C; The University of Bristol, Bristol, UK.
  • Dive C; The University of Bristol, Bristol, UK.
  • Cooksley T; The Christie NHS Foundation Trust, Manchester, UK.
  • Palmieri C; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
  • Freitas A; The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
  • Armstrong AC; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
ESMO Open ; 6(2): 100056, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1237691
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: ESMO Open Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: ESMO Open Year: 2021 Document Type: Article